Can a pill block a key tumor driver? a new trial aims to find out
Disease control
Recruiting now
This early-stage trial is testing an experimental oral drug called KNT-0916 in adults with advanced solid tumors that have specific changes in the FGFR2 gene. The study aims to see if the drug is safe, tolerable, and shows signs of shrinking or controlling tumors. Participants mu…
Phase 1 • Sponsor: KinoTeck Therapeutics Co., Ltd • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC